UTHR compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name

UTHRUnited Therapeutics Corp

Mkt capRevenueRevenue

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

UTHRUnited Therapeutics Corp

MDGLMadrigal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

UTHR

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±6.2%▲+1.19%×0.19

Q2 FY26±6.1%▲+0.06%×0.02

May 6 '26—▲+4.29%—

Q1 FY26—▲+13.03%—

MDGL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.7%▼−8.08%×0.64

Q2 FY26±10.5%▼−9.83%×0.93

= impliedUTHR realized, solidMDGL realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

Q1 FY26

±9.2%

▲+7.42%

×0.80

Feb 19 '26±6.2%▼−11.11%×1.79

UTHRUnited Therapeutics Corp

565.64▼−0.01%· post 557.33

Mkt cap$23.9BRevenue$833MQ3 FY26Revenue$3.2BFY25

MDGLMadrigal Pharmaceuticals, Inc.

396.55▼−0.89%· post 403.00

ClosedNov 6 '26

Mkt cap$9.3BRevenue$431MQ3 FY26Revenue$958MFY25

Compare

ClosedNov 6 '26

UTHRUnited Therapeutics Corp

MDGLMadrigal Pharmaceuticals, Inc.

565.64▼−0.01%post 557.33

Price

396.55▼−0.89%post 403.00

$23.9B

Mkt cap

$9.3B

Q3 FY26$833M

Revenue

$431MQ3 FY26

FY25$3.2B

Revenue

$958MFY25

UTHR565.64▼−0.01%vsMDGL396.55▼−0.89%ClosedNov 6 '26